Patient engagement in 2030: how can patient engagement contribute towards building a new ecosystem for drug development and therapy
Save the date 3 December 2020 in the Netherlands, We will update this page and publish a more detailed program, venue location, and registration form shortly.
Patient engagement has become one of the key elements in drug development and therapy during recent years and becomes more important as time progresses. At the same time, these processes are undergoing change towards a new ecosystem. By taking the lessons learned from the past, taking current initiatives, and bright ideas for the future, patient engagement plays a crucial role in the future of drug development & therapy.
Start your development with the end in mind!
On December 3rd, 2020, admedicum Business for Patients will organize an event in collaboration with HollandBIO in the Netherlands. Patient representatives will kick off the event with their input and subsequently multiple stakeholder speakers from healthcare, regulatory and industry will share constructive perspectives towards solutions, improvements, and opportunities for patient engagement in 2030. The stakeholder talks will be warm-up and be followed by an interactive and open ‘parliamentary-style’ debate among participants.
See you in December!